Quarterly report · Q2
6960.TEDINET S100S7MX
Period2023-04-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥66.5bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥134.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥62.6bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥14.0bn | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥11.1bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥14.1bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥25.1bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥11.7bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥14.3bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥11.8bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥9.8bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥17.3bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥8.1bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥9.8bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥8.1bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥210.8bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥206.9bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥196.9bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥39.3bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥43.9bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥171.5bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥163.0bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥155.1bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥70.5bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥68.0bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥67.5bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥64.9bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥63.4bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥61.0bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥10.4bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥23.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥11.3bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥4.8bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥14.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥6.5bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥3.2bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥5.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥3.1bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥324.32 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥208.78 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥571.25 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥268.43 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥174.15 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 81.3% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.8% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.8% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥20.5bn |
| jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥20.5bn |
| jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥4.1bn |
| jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥29.3bn |
| jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥29.3bn |
| jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥6.7bn |
| jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥3.8bn |
| jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥3.8bn |
| jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥737m |
| jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥13.0bn |
| jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥13.0bn |
| jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥2.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥66.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥66.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥14.0bn |
| jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥17.1bn |
| jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥17.1bn |
| jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥2.1bn |
| jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥26.9bn |
| jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥26.9bn |
| jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥6.0bn |
| jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥5.2bn |
| jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥5.2bn |
| jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥881m |
| jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥13.4bn |
| jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥13.4bn |
| jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥2.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥62.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥62.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥11.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 520
| Item | Context | Value | Unit |
|---|---|---|---|
| Comprehensive income | Prior1YTDDuration | 8401000000 | JPY |
| Comprehensive income | CurrentYTDDuration | 11474000000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 8401000000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 11474000000 | JPY |
| Income before income taxes | Prior1YTDDuration | 11792000000 | JPY |
| Income before income taxes | CurrentYTDDuration | 14280000000 | JPY |
| Depreciation and amortization ope cf | Prior1YTDDuration | 4553000000 | JPY |
| Depreciation and amortization ope cf | CurrentYTDDuration | 4611000000 | JPY |
| Impairment loss ope cf | Prior1YTDDuration | 58000000 | JPY |
| Impairment loss ope cf | CurrentYTDDuration | 4000000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | Prior1YTDDuration | -15000000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | CurrentYTDDuration | 0 | JPY |
| Increase decrease in provision for bonuses ope cf | Prior1YTDDuration | -536000000 | JPY |
| Increase decrease in provision for bonuses ope cf | CurrentYTDDuration | -958000000 | JPY |
| Increase decrease in provision for product warranties ope cf | Prior1YTDDuration | 13000000 | JPY |
| Increase decrease in provision for product warranties ope cf | CurrentYTDDuration | -8000000 | JPY |
| Increase decrease in net defined benefit liability ope cf | Prior1YTDDuration | 67000000 | JPY |
| Increase decrease in net defined benefit liability ope cf | CurrentYTDDuration | 64000000 | JPY |
| Increase decrease in other provision ope cf | Prior1YTDDuration | -455000000 | JPY |
| Increase decrease in other provision ope cf | CurrentYTDDuration | -310000000 | JPY |
| Interest and dividends income ope cf | Prior1YTDDuration | -130000000 | JPY |
| Interest and dividends income ope cf | CurrentYTDDuration | -154000000 | JPY |
| Interest expenses ope cf | Prior1YTDDuration | 17000000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 16000000 | JPY |
| Loss gain on sales of noncurrent assets ope cf | Prior1YTDDuration | -7000000 | JPY |
| Loss gain on sales of noncurrent assets ope cf | CurrentYTDDuration | -4000000 | JPY |
| Loss gain on investments in partnership ope cf | Prior1YTDDuration | -17000000 | JPY |
| Loss gain on investments in partnership ope cf | CurrentYTDDuration | -1000000 | JPY |
| Loss gain on valuation of investment securities ope cf | Prior1YTDDuration | 48000000 | JPY |
| Loss gain on valuation of investment securities ope cf | CurrentYTDDuration | － | JPY |
| Loss gain on extinguishment of tie in shares ope cf | Prior1YTDDuration | -67000000 | JPY |
| Loss gain on extinguishment of tie in shares ope cf | CurrentYTDDuration | － | JPY |
| Loss gain on cancellation of insurance contract ope cf | Prior1YTDDuration | -163000000 | JPY |
| Loss gain on cancellation of insurance contract ope cf | CurrentYTDDuration | -194000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YTDDuration | 4534000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | 4950000000 | JPY |
| Decrease increase in inventories ope cf | Prior1YTDDuration | -2319000000 | JPY |
| Decrease increase in inventories ope cf | CurrentYTDDuration | -2778000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | -1598000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | -2318000000 | JPY |
| Increase decrease in accrued consumption taxes ope cf | Prior1YTDDuration | 376000000 | JPY |
| Increase decrease in accrued consumption taxes ope cf | CurrentYTDDuration | -793000000 | JPY |
| Other net ope cf | Prior1YTDDuration | -592000000 | JPY |
| Other net ope cf | CurrentYTDDuration | -709000000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | 15560000000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | 15695000000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YTDDuration | 129000000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 133000000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -17000000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -17000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |